All In MedTech

Device Trial Radar · NCT06578650

A Prospective, Single-arm, Clinical Trial of Electrospun Fiber Matrix (Restrata) in the Treatment of Surgical Defects Secondary to Resection of Malignant Cutaneous Neoplasms

Last checked: Nov 19, 2026Latest source record: Jun 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

34

Planned (sponsor's estimate)

Start

Oct 31, 2024

Primary completion

Aug 2027

Study completion Oct 2027

Sponsor

Lead sponsor
Acera Surgical, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Aug 29, 2024

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this observational prospective study is to evaluate wound healing outcomes in resection wounds resulting from surgical removal of cutaneous malignancies treated with a synthetic electrospun fiber matrix. This study intends to quantify the time from initial resection and product application to time of complete granulation of the wound bed in weeks.

Conditions

  • Surgical Wound

Interventions

  • Synthetic Electrospun Fiber MatrixDevice

    Patients who are eligible for enrollment will be treated with Synthetic Electrospun Fiber Matrix immediately after surgical resection to the resulting wound

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to wound bed granulationTime frame: Weekly assessments until granulation achieved or up to 6 weeks following resection surgery

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University Nevada - Las Vegas

    Las Vegas, Nevada · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.